Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of BCAB will rise by +1.66% over the next 2 Weeks and hit $0.73 by Tuesday, January 13, 2026. In that time frame, BCAB's share price is expected to range between $0.57 and $0.89.
BearishAverageBullishBCAB shares fell -20.82% in Wednesday, December 31, 2025's trading session, dropping from a previous close of $0.72 to move at $0.57. The stock demonstrated notable intraday movement (see BCAB's key stats for a full breakdown), fluctuating between $0.55 and $0.82, a +49.27% trading range. While recent weeks have seen some volatility, BCAB has managed to secure a -25.31% drop over the past 2 weeks. The downward price movement was accompanied by increased trading volume, with approximately 7.95M shares changing hands, 5.22M more than the previous session. This amounted to $4.51M in total market activity.
Will BCAB Continue Its Upward Trend?
According to analyst ratings and projections for BCAB, BioAtla, Inc. shares are anticipated to increase by +36.18%, potentially reaching $0.89 per share by January 13, 2026. Short-term technical indicators currently suggest a neutral sentiment for BCAB. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 12 positive trading days within the past 30 sessions. Based on the BCAB stock forecast, now is a good time to buy BCAB stock because its current trading price is -22.12% below our predicted value, hinting at a possible overvaluation. For deeper insights, view our sentiment analysis on BCAB covering social and institutional perspectives.
BCAB Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into BCAB's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 32.23% to 40.76%) suggest weak bearish momentum with possible fluctuation. The 50-day RSI, at 47.13%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 48.29%, maintains a neutral outlook for the long term. Insights into BCAB's shareholder base show how institutional investors are positioning themselves during these momentum shifts
BioAtla, Inc. Monthly Forecast 2026
January 2026
According to our latest forecast models, BioAtla, Inc. (BCAB) is positioned to show a strong performance in January 2026. The price is predicted to move between $0.80 and $1.87, settling at an average of $1.14. This could translate to a +100.81% gain.
February 2026
Based on current market signals, BioAtla, Inc. is projected to trend february 2026. We forecast a trading range from $0.49 to $1.01, with a likely average price of $0.71. Investors could expect a potential return of +25.07%.
March 2026
Our predictive algorithms indicate BioAtla, Inc. stock may see a shift in March 2026. The expected range spans $0.50–$1.03, with an average target of $0.80. This represents a positive outlook and a possible gain of +40.92%.
April 2026
Analyzing established trends, BioAtla, Inc. looks set to move in April 2026. Projections place the stock between $0.55 and $1.51, averaging around $1.18. This suggests a +107.86% gain from current levels.
May 2026
Market indicators suggest BioAtla, Inc. could experience notable changes during May 2026. Prices could fluctuate within $0.39 to $1.14, with a midpoint forecast of $1.14. The stock might deliver a +100.81% gain.
June 2026
Forecasting for June 2026, models estimate that BioAtla, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $1.05, averaging $1.31. This signals a positive trajectory with potential returns around +130.76%.
July 2026
According to our latest forecast models, BioAtla, Inc. (BCAB) is positioned to show a strong performance in July 2026. The price is predicted to move between $0.00 and $0.76, settling at an average of $1.12. This could translate to a +97.29% gain.
August 2026
Based on current market signals, BioAtla, Inc. is projected to trend august 2026. We forecast a trading range from $0.00 to $0.66, with a likely average price of $1.63. Investors could expect a potential return of +187.12%.
September 2026
Our predictive algorithms indicate BioAtla, Inc. stock may see a shift in September 2026. The expected range spans $0.00–$0.40, with an average target of $1.86. This represents a positive outlook and a possible gain of +227.64%.
October 2026
Analyzing established trends, BioAtla, Inc. looks set to move in October 2026. Projections place the stock between $0.00 and $0.11, averaging around $1.90. This suggests a +234.68% gain from current levels.
November 2026
Market indicators suggest BioAtla, Inc. could experience notable changes during November 2026. Prices could fluctuate within $0.00 to $0.13, with a midpoint forecast of $2.43. The stock might deliver a +328.04% gain.
December 2026
Forecasting for December 2026, models estimate that BioAtla, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $0.00 and $0.54, averaging $2.45. This signals a positive trajectory with potential returns around +331.57%.
BCAB's history of dividends and stock splits also plays a role in long-term investor confidence.